富瑞:下調李寧(2331.HK)目標至32.5港元 看好其新零售模式
富瑞發表研究報告指,李寧(2331.HK)的管理層料今年的淨利潤能達10-10.5%增長。富瑞相信,李寧新的零售模式能成為非常有效的障礙予競爭對手。該行重申其“買入”投資評級,目標價由32.8港元下調至32.5港元。
富瑞表示,李寧下一步將會建立顧客及產品的數據庫,能有效獲得市場反應。該行又指,李寧新的零售模式能使多品牌的營運商需要更多時間及資源獲得及分析數據,而海外競爭則需要依賴分銷商測試過程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.